Lumateperone-13Cd3

SL-9605

Lumateperone-¹³Cd₃, >98%

Related CAS No. : [313368-91-1] of the unlabelled compound

Synonyms : ITI-007-¹³Cd₃

IUPAC Name : 1-(4-Fluorophenyl)-4-((6bR,10aS)-3-(methyl-¹³C-d₃)-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : This is a double labelled labelled version of Lumateperone, which is an orally active compound that acts as a 5-HT2A receptor antagonist (Ki = 0.54 nM), a partial agonist at presynaptic D2 receptors, an antagonist at postsynaptic D2 receptors (Ki = 32 nM), and a dopamine D1 receptor modulator. Lumateperone has been investigated for its anticancer properties and is also used in research related to schizophrenia and bipolar depression.

References : Zhang J. et al.: Mol Inform., e2200011, 2022; Titulaer J. et al.: Eur. Neuropsychopharmacol., 62, 22-35, 2022.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.